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Tissue-resident intestinal intraepithelial T lymphocytes (T-IEL) patrol the gut and have important roles in 15 
regulating intestinal homeostasis. T-IEL include both induced T-IEL, derived from systemic antigen-16 
experienced lymphocytes, and natural IEL, which are developmentally targeted to the intestine. While the 17 
processes driving T-IEL development have been elucidated, the precise roles of the different subsets and 18 
the processes driving activation and regulation of these cells remain unclear. To gain functional insights into 19 
these enigmatic cells, we used high-resolution, quantitative mass spectrometry to compare the proteomes of 20 
induced T-IEL and natural T-IEL subsets, with naive CD8
+
 T cells from lymph nodes. This data exposes the 21 
dominant effect of the gut environment over ontogeny on T-IEL phenotypes. Analyses of protein copy 22 
numbers of >7000 proteins in T-IEL reveal skewing of the cell surface repertoire towards epithelial 23 
interactions and checkpoint receptors; strong suppression of the metabolic machinery indicating a high 24 
energy barrier to functional activation; upregulated cholesterol and lipid metabolic pathways, leading to high 25 
cholesterol levels in T-IEL; suppression of T cell antigen receptor signalling and expression of the 26 
transcription factor TOX, reminiscent of chronically activated T cells. These novel findings illustrate how T-27 
IEL integrate multiple tissue-specific signals to maintain their homeostasis and potentially function. 28 
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The presence of tissue resident immune cells enables a quick response to either local stress, injury or 33 
infection. Understanding the functional identity of immune cells and their shaping by the tissue environment 34 
is therefore critical to understanding tissue immunity. Intestinal intraepithelial T lymphocytes (T-IEL) reside 35 
within the intestinal epithelium and consist of a heterogenous mix of natural and induced T-IEL (Olivares-36 
Villagómez and Van Kaer, 2018). All T-IEL express a T cell antigen receptor (TCR), consisting of either αβ, 37 
or γδ chains, alongside TCR co-receptors, i.e., CD8αβ or CD8αα and to a lesser extent CD4(+/-). The most 38 
prevalent IEL subsets within the epithelium of the murine small intestine are derived directly from thymus 39 
progenitors, so-called natural, or unconventional T-IEL. These natural T-IEL express either TCRγδ and 40 
CD8αα (TCRγδ CD8αα T-IEL), which account for ~50% of the total T-IEL pool, or express TCRαβ and 41 





 double negative (DN) progenitors in the thymus by agonist selection. Conversely, induced T-43 




 αβ T cells that are induced to establish tissue-44 
residency within the intestinal epithelium, most likely in response to cues from dietary antigens and the 45 
microbiota, as evidenced by a strong reduction in their numbers in germ-free and protein antigen-free mice 46 
(Di Marco Barros et al., 2016). These induced T-IEL (TCRβ CD8αβ T-IEL) are believed to have substantial 47 
overlap with tissue-resident memory T (TRM) cells  (Sasson et al., 2020) and are present in high numbers in 48 
human intestines. How these induced T-IEL are formed, their functional importance, and the role of the gut 49 
environment in deciding their fate are still the focus of intense study.  50 
Residing at the forefront of the intestinal lumen, T-IEL are exposed to a range of commensal bacteria and 51 
their metabolites, dietary metabolites and antigens, and potential pathogens. These immune cells are 52 
therefore faced with the conflicting tasks of protecting the intestinal barrier, while also preventing 53 
indiscriminate tissue damage. Previous gene expression studies have identified T-IEL as having an 54 
‘activated-yet-resting’ phenotype, with the expression of several activation markers, such as Granzymes and 55 
CD44, along with inhibitory receptors, such as the Ly49 family and CD8αα (Denning et al., 2007; Fahrer et 56 
al., 2001; Shires et al., 2001). Yet it is still unclear how T-IEL are kept in check at steady-state (Vandereyken 57 
et al., 2020). T-IEL effector responses can get dysregulated in chronic inflammatory conditions, such as 58 
celiac disease and inflammatory bowel diseases, therefore we need insight into the regulation of these cells. 59 
Moreover, we lack an understanding of how T-IEL are programmed to respond to specific epithelial signals, 60 
and how this is dictated and regulated by the tissue microenvironment.  61 
In this study, we use quantitative proteomics to explore the differences between induced T-IEL and systemic 62 
T cells from lymph nodes (LN), from which induced T-IEL are ostensibly derived. We also compare induced 63 
T-IEL with the natural TCRγδ and TCRαβ T-IEL subsets in the gut. Our findings suggest that the tissue 64 
environment largely overrides any developmental imprinting of the cells to define the proteomic landscape of 65 
intestinal resident T-IEL, and reveal important metabolic and protein translation constraints to T-IEL 66 
activation. Importantly, we also uncover evidence of chronic T cell activation potentially driving a partially 67 
exhausted phenotype in both the induced and natural T-IEL subsets.  68 
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Tissue microenvironment defines intestinal T-IEL as distinct from systemic T cells 71 
CD8
+
 T-IEL subsets were purified from wild type (WT) murine small intestinal epithelial preparations to 72 
greater than 95% purity by cell sorting (Figure 1-– figure supplement 1). Next, high resolution mass 73 
spectrometry (MS) was performed to obtain an in-depth characterisation of the proteomes of the three main 74 
CD8
+
 T-IEL subsets in the intestine. Tandem mass tags (TMT) were used with synchronous precursor 75 
selection (SPS) to obtain the most accurate quantifications for all populations (Figure 1a). To evaluate how 76 
T-IEL related to other immune populations, we first compared the proteomes of T-IEL with other TMT-based 77 
proteomes of various T cell populations currently available within the Immunological Proteome Resource 78 
(ImmPRes http://immpres.co.uk ), an immune cell proteome database developed in-house (Howden et al., 79 
2019). Even though T-IEL are thought to have an effector-like phenotype, by using Principal Component 80 
Analysis (PCA), we found that T-IEL were much more similar to ex-vivo naïve CD8
+
 T cells, than to in-vitro 81 
activated, effector cytotoxic T cells (CTL) (Figure 1b). Hence, we did an in-depth, protein-level comparison 82 
of the three T-IEL subsets with two naïve CD8
+
 T cells from the lymph nodes (LN). The two LN naïve CD8
+
 T 83 
cells used here, were either derived from WT mice, similar to the T-IEL, or from P14 transgenic mice, which 84 
express a T cell antigen receptor (TCR) specific for a peptide derived from lymphocytic choriomeningitis 85 
virus (LCMV). P14 T cells were included as a genetically and developmentally distinct comparator for WT LN 86 
T cells. To enable cross-comparisons, all 5 populations were acquired using the same TMT-based SPS-MS3 87 
method and they were all analysed together using MaxQuant (Cox and Mann, 2008). The data were 88 
searched using a 1% false discovery rate (FDR) at the protein and peptide spectrum match (PSM) level (for 89 
more details see methods). This provided an in-depth overview of the proteome, with over 8,200 proteins 90 
detected in total, where each of the 5 populations showed similar coverage, ranging from 6,500 to 7,500 91 
proteins detected in all of them (Figure 1c).  92 
For all downstream analyses we converted the raw mass spectrometry intensity values into estimated 93 
protein copy numbers using the ‘proteomic ruler’ (Wisniewski et al., 2014). First, these copy numbers were 94 
used to estimate the total protein content for all 5 populations, which revealed no major differences in most, 95 
except for the TCRγδ CD8αα T-IEL which displayed a slightly higher protein content than the rest (Figure 96 
1d). Next, the copy numbers were used as input for a second dimensionality reduction analysis via PCA, 97 
focussed now on comparing the T-IEL and LN populations. The results indicated that across the first 98 
component, which explains 44% of variance, there was a clear separation between T-IEL and LN 99 
populations (Figure 1e), highlighting that the 3 T-IEL subsets share much closer identity to each other, than 100 
to the naïve LN T cell populations.    101 
To explore these results further we compared each population to each other. As induced TCRαβ CD8αβ T-102 
IEL are thought to be derived from systemic T cells that respond to antigen in organised lymphoid structures, 103 
and then migrate into intestinal tissues, we first compared their proteome to the systemic WT LN TCRαβ 104 
CD8αβ T cells. Unexpectedly, the Pearson correlation coefficient comparing the estimated protein copy 105 
number of TCRαβ CD8αβ T- IEL and the WT LN TCRαβ CD8αβ T cells, was only 0.85, the lowest value in 106 
all the comparisons (Figure 1f). In contrast, the proteomes of induced T-IEL and the so-called natural Τ-IEL 107 
populations, showed greater similarity with a correlation >0.93 (Figure 1g,h), while the correlation between 108 
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LN T cells from WT to P14 TCR transgenic mice was 0.92 (Figure 1i). These analyses indicated that 109 
induced T-IEL share a very similar expression profile to natural T-IEL. The comparisons to LN T cells 110 
revealed that even LN T cells derived from two different strains of mice were much more similar to each 111 
other than to induced T-IEL.  112 
To further explore similarities and differences between induced T-IEL and LN T cells we focussed on the 113 
TCRαβ CD8αβ T-IEL and the WT LN TCRαβ CD8αβ T cells (LN). We first performed a global analysis of the 114 
most abundant protein families that represent the top 50% of the proteome. This overview revealed some 115 
similarities and some important proteomic differences between the two cell types. Though the histone 116 
content and the glycolytic enzymes looked very similar, there were big differences in proteins related to the 117 
ribosomes, the cytoskeleton and the cytotoxic granules (Figure 2a). The LN population had nearly double 118 
the number of ribosomal proteins, while the T-IEL displayed higher cytoskeletal and cytotoxic proteins. 119 
These proteomic differences were not exclusive to TCRαβ CD8αβ T-IEL, as the same pattern was observed 120 
within both natural T-IEL subsets. Perhaps the most striking difference between naïve LN T cells and T-IEL 121 
was the expression levels of Granzymes (Figure 2b). Granzyme A (GzmA) was expressed at >20 million 122 
copies per cell in each of the natural T-IEL subsets, and at 9-10 million molecules per cell in the induced T-123 
IEL population. This was more than double what was previously identified in cytotoxic CD8
+
 T cells (Howden 124 
et al., 2019). Granzyme B (GzmB), which was expressed at ~20 million copies per cell in CTL, was 125 
expressed at between 4 to 10 million copies per cell in all 3 T-IEL subsets. T-IEL also express Granzyme C 126 
(GzmC) and K (GzmK), although at <100,000 molecules per cell each (Figure 2b), making their general 127 
expression of Granzymes either comparable to, or higher than, in vitro-generated CTL. This substantial 128 
commitment to Granzyme expression is consistent with the expression of the whole cytotoxic machinery, 129 
including perforin and key molecules involved in degranulation (Supplementary File 1, (James et al., 130 
2020)), all of which are either barely detectable, or altogether absent, in the naïve T cells. Thus, these data 131 
support the hypothesis that all T-IEL in the gut are geared towards cytotoxic activity.  132 
To obtain an unbiased overview of the differences between the induced T-IEL and the LN T cell populations, 133 
we performed an overrepresentation analysis (ORA) focussed on Gene Ontology (GO) terms related to 134 
biological processes (Figure 2c-d; Supplementary Files 2,3). The data indicated that proteins which were 135 
significantly increased in expression in induced T-IEL were highly enriched in cholesterol and lipid 136 
metabolism, intestinal absorption and xenobiotic metabolism and processes involving cytoskeletal proteins, 137 
such as cell-cell adhesion and integrin-mediated signalling. Conversely, proteins which were significantly 138 
higher expressed in LN T cells were enriched for terms relating to ribosomal proteins and ribonuclease P 139 
activity.  140 
 141 
Downregulation of protein synthesis in T-IEL 142 
Based on the results obtained from the ORA, we next focussed on the protein machinery involved with the 143 
ribosomes and protein synthesis. A comparison of the total estimated copy numbers for ribosomal proteins 144 
indicated that LN T cells express almost double the amount expressed in any of the T-IEL subsets (Figure 145 
3a). This was true for both cytoplasmic and mitochondrial ribosomal proteins, with the latter being the most 146 
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reduced in T-IEL, compared to LN T cells. The decreased expression of ribosomal proteins in T-IEL was 147 
mirrored by the decreased expression of RNA polymerases I (Pol1) and III (Pol3), which transcribe, 148 
respectively, ribosomal RNA and transfer RNA (Figure 3b). For the subunits of both the Pol1 and Pol3 149 
complexes, the median fold reduction in T-IEL was greater than 5-fold when compared to LN T cells (Figure 150 
3- figure supplement 1). Strikingly, the subunits specific for RNA polymerase II (Pol2), which transcribes 151 
protein-coding genes, did not display a reduction in median expression levels. These data suggest that while 152 
ribosomal expression is reduced, mRNA pools could potentially still be maintained in T-IEL.  153 
To maintain protein synthesis, consistent uptake of amino acids is generally required. However, our data 154 
show that T-IEL express low levels (<2000 copies per cell) of 3 key amino acid transporters, i.e., SLC1A5, 155 
SLC7A5 and SLC38A2 (Figure 3c), all of which are highly upregulated upon T cell activation with SLC7A5 156 
being expressed at >400,000 copies in effector T cells (Howden et al., 2019). SLC7A5 expression levels 157 
have been reported to directly control the expression of ribosomal proteins and other important translation 158 
machinery components (Marchingo et al., 2020; Sinclair et al., 2019). The very low levels of amino acid 159 
transporters detected in T-IEL is therefore expected to limit protein synthesis. Furthermore, despite having 160 
low levels of amino acid transporters, enzymes involved in amino acid catabolism, such as arginase-2 161 
(ARG2) and alanine aminotransferase (Glutamic-Pyruvic Transaminase, GPT), are highly expressed in T-162 
IEL, also suggesting reduced protein synthesis in T-IEL (Figure 3d). Interestingly, high expression of ARG2 163 
was also accompanied by upregulated expression of other enzymes from the urea cycle (Figure 3- figure 164 
supplement 1). Finally, it is also notable that T-IEL express significantly higher levels of PRKR-Like 165 
Endoplasmic Reticulum Kinase (PERK), than LN T cells. PERK functions as a global protein synthesis 166 
inhibitor, either in the presence of unfolded proteins, or upon low amino acid availability (Figure 3e). We 167 
therefore decided to measure the protein synthesis rates in T-IEL and LN T cells by O-propargyl puromycin 168 
(OPP) incorporation into nascent peptide chains and compared with cycloheximide-treated controls. The 169 
data from the OPP assay highlighted almost undetectable levels of protein translation in all 3 T-IEL subsets 170 
(Figure 3f), which correlated well with the reduced ribosomal content, low expression of amino-acid 171 
transporters and high catabolic enzymes identified within the proteomes of T-IEL. In contrast, LN T cells 172 
contain more actively translating ribosomes than T-IEL, providing orthogonal validation of the proteomic 173 
data. It should be noted that naïve T cells have been reported to have low protein synthesis rates (Wolf et 174 
al., 2020), however, our data indicate even lower synthesis rates in T-IEL. Thus, multiple mechanisms 175 
appear to be active in T-IEL to keep protein synthesis at a minimum.  176 
T-IEL have a unique metabolic profile  177 
Recent studies have shown a direct correlation between metabolic activity and the rates of protein synthesis 178 
in T cells (Argüello et al., 2020). The very low levels of protein synthesis in all 3 T-IEL subsets therefore 179 
prompted us to further explore the bioenergetic profile of T-IEL. Globally, we did not find any major 180 
differences in the proportion of the T-IEL proteomes dedicated to the major metabolic pathways compared to 181 
naïve T cells (Figure 4a). We did however find that all 3 T-IEL subsets express substantial levels of the 182 
GLUT2 (~5,000 copies) and GLUT3 (~35,000 copies), both facilitative glucose transporters (Figure 4b). 183 
GLUT2 is normally found in intestinal and other epithelial cells, not in immune cells, and is a low affinity 184 
bidirectional glucose transporter. GLUT3 is a high affinity glucose transporter that is thought to be particularly 185 
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important in CD8 T cell activation (Geltink et al., 2018). Glucose can be utilised in T cells through either 186 
glycolysis, or oxidative phosphorylation (OXPHOS) and the tricarboxylic acid (TCA) cycle that also provides 187 
biosynthetic intermediates (Ma et al., 2019). We therefore examined the expression of proteins involved in 188 
these pathways in T-IEL. We find that T-IEL express most of the proteins of the glycolytic and TCA pathways 189 
at similar levels to naïve T cells (Figure 4c). With one exception being the lactate transporters, SLC16A1 190 
and SLC16A3, which even though they are significantly higher than in naïve T cells, are still expressed at 191 
very low levels, indicating a low glycolytic potential within these cells. Furthermore, T-IEL have also been 192 
shown to have comparably low OXPHOS potential as in naïve T cells (Konjar et al., 2018). Thus, the function 193 
of the glucose being taken up through the T-IEL glucose transporters remains unclear.  194 
We also examined the mitochondrial protein content of T-IEL. The total mitochondrial protein content 195 
appeared to be significantly reduced, however, all the components of the electron transport chain (ETC) 196 
were expressed at similar levels in all T-IEL, as in LN T cells (Figure 4d). These data suggest that T-IEL 197 
mitochondria have similar respiratory capacity to naïve T cells. Naïve T cells use OXPHOS and fatty acid 198 
oxidation (FAO) to maintain their cellular functions. Therefore, we assessed FAO enzyme expression in T-199 
IEL, and found this was also largely similar to naïve T cells (Figure 4c).  Interestingly, some proteins 200 
involved in peroxisomal FAO, including the transporter ABCD4, the key peroxisomal beta-oxidation enzymes 201 
acyl-CoA oxidase ACOX1, and Carnitine O-Acetyltransferase (CrAT), were more highly expressed in T-IEL 202 
than in naïve T cells. Peroxisomal FAO produces Acetyl CoA, which can be used within the TCA cycle, and 203 
NADH, which can be utilised in the ETC, to contribute to energy production. NADH produced during FAO 204 
and OXPHOS needs to be transported into the mitochondria through a redox shuttle, and in this context, we 205 
find that the glycerol-3-phosphate shuttle is only expressed in T-IEL (Figure 4e). Put together, these data 206 
suggest that peroxisomes may be a source of fuel to support the low levels of energy produced in T-IEL, and 207 
indicate key differences in the metabolic pathways active in T-IEL.  208 
T-IEL have increased lipid biosynthesis and cholesterol metabolism 209 
Our data would seem to indicate that T-IEL have low bioenergetic production and requirements. However, 210 
functional annotation of proteins enriched in induced T-IEL indicate over-representation of cholesterol and 211 
steroid metabolism pathways, and the metabolism of chemicals and inorganic compounds (Figure 2c). T-IEL 212 
are highly enriched in proteins involved in xenobiotic metabolism, including members of the UDP 213 
glucuronosyl transferase (UGT) family, Glutathione S-transferase (GST) and Cytochrome P450 (CYP) 214 
enzymes (Supplementary File 1). Detailed examination of the cholesterol biosynthetic pathway indicates 215 
almost all the enzymes are expressed highly in all T-IEL, as compared to LN T cells (Figure 5a). This 216 
pathway is controlled by the master regulator sterol-regulatory element binding protein 2 (SREBP2) 217 
(Madison, 2016), which the data show is exclusively expressed within the 3 T-IEL populations (Figure 5b). 218 
We therefore measured cholesterol content in T-IEL, and found that indeed all 3 subsets have greater than 219 
2.5-fold more cholesterol than naïve LN CD8 T cells (Figure 5c). 220 
T-IEL also express the fatty acid transport proteins (FATP2(Slc27a2) and FATP4 (Slc27a4)), which are 221 
necessary for uptake and transport of long chain fatty acids, as well as fatty acid binding proteins (FABP1, 2, 222 
5 and 6), which also contribute to uptake and transport of fatty acids to the endoplasmic reticulum (ER) 223 
(Figure 5d,e). In addition to the intestinal specific family member, FABP2 (>350,000 copies/cell), the liver 224 
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FABP, FABP1 (>200,000 copies/cell), which is highly expressed in the proximal intestine, and the ileal 225 
FABP, FABP6 or Gastrotropin (>10,000 copies/cell), are all also highly expressed in all 3 T-IEL subsets 226 
(Figure 5e). It is interesting to note that FABP5, which was previously identified as being expressed in skin 227 
TRM cells, but not in intestinal TRM at the mRNA level (Frizzell et al., 2020), was detected at >200,000 228 
molecules per cell in all 3 T-IEL. Skin TRM appear to use increased exogenous fatty acids uptake to feed into 229 
mitochondrial FAO, thus supporting their maintenance and survival (Pan et al., 2017). However, carnitine O-230 
palmitoyl transferase (CPT1A), the rate-limiting enzyme for mitochondrial FAO of long chain fatty acids is 231 
expressed at lower levels in T-IEL compared to naive LN T cells (Figure 4c). This suggests that the highly 232 
increased lipid transporter expression in T-IEL is not solely used to drive FAO. 233 
T-IEL are also enriched in proteins involved in the two major pathways of triacylglycerol (TAG or triglyceride) 234 
synthesis expressed in the intestine (Figure 5f) (Yen et al., 2015). TAG is hydrophobic and is either stored 235 
transiently in the cytosol in lipid droplets or assembled and secreted from enterocytes in apolipoprotein B 236 
(ApoB)-containing chylomicrons, or lipoproteins that also contain cholesterol and cholesteryl esters. 237 
Surprisingly, T-IEL also express high levels of a key cholesterol esterification enzyme, Acyl CoA:cholesterol 238 
acyl transferase 2, ACAT-2 (Soat2), which is thought to be specifically expressed in enterocytes (Pan and 239 
Hussain, 2012). Esterification of cholesterol increases its hydrophobicity for efficient packaging into 240 
lipoproteins. We therefore also explored the expression of enzymes involved in lipoprotein assembly. 241 
Lipoprotein assembly involves the packaging of TAG and cholesteryl esters by the microsomal triglyceride 242 
transfer protein (MTP, Mttp) into ApoB-lipid conjugates, followed by export out of the cells by the core protein 243 
complex II (COPII) (Hussain et al., 2012). MTP was highly expressed in T-IEL with over 80,000 copies per 244 
cell, while less than 100 copies were identified in LN T cells. Similarly, ApoB and the GTPase SAR1b, a key 245 
component of the COPII complex, were also expressed in T-IEL at higher copies than in LN T cells (Figure 246 
5f). Together, these data suggest that T-IEL also take up and metabolise fatty acids and cholesterol, and 247 
further, have the capacity to package these lipids into lipid droplets and potentially even transport them out of 248 
the cells.  249 
Intestinal T-IEL proteome contains cell surface receptors for epithelial and neuroimmune interactions 250 
We also explored the expression of proteins uniquely identified in T-IEL and found several proteins involved 251 
in cell adhesion, cytoskeleton remodelling and integrin signalling. Strikingly, all T-IEL subsets expressed 252 
numerous epithelial cell adhesion molecules and integrins which are not found on naïve LN T cells (Figure 253 
6a). Although these results are consistent with the localisation of T-IEL within the gut epithelial layer, we 254 
were surprised to find T-IEL proteomes also contained many tight junction, adherens junction and 255 
desmosome-associated proteins, which are normally expressed on intestinal epithelial cells, such as E-256 
Cadherin (E-Cad), ZO-2, desmoplakin, Villin-1 and JAM-A (F11R) (Figure 6a,b). These proteins could 257 
potentially be contaminants from epithelial cells in the sample preparation, however, E-Cad, Occludin and 258 
EpCAM have been detected both at the RNA and protein level in T-IEL (Figure 6- figure supplement 1, 259 
(Inagaki-Ohara et al., 2005; Nochi et al., 2004)). Moreover, immunofluorescence imaging and flow cytometry 260 
confirmed expression of ZO-2, E-Cad and EpCAM in T-IEL, suggesting that T-IEL could use these molecules 261 
to navigate the tissue environment (Figure 6c, Figure 6- figure supplement 1). Conversely, endothelial cell 262 
adhesion molecules such as PECAM-1 and L-selectin, that facilitate T cell migration into secondary lymphoid 263 
   
 
   
 
9 
organs, were highly expressed on naïve T cells, but not on T-IEL, as befits their tissue resident status 264 
(Figure 6d). 265 
T-IEL proteomes also suggest that T-IEL could be communicating with the enteric nervous system. TCRγδ 266 
CD8αα T-IEL express two neural cell adhesion molecules, NCAM1 (CD171) and NrCAM, both implicated in 267 
homophilic adhesion and in axonal growth and guidance. Furthermore, two neuropeptide receptors, GPR171 268 
and VIPR2, were also identified in T-IEL proteomes (Figure 6b). BigLEN and vasoactive intestinal peptide 269 
(VIP) bind to GPR171 and VIPR1/VIPR2, respectively (Delgado et al., 2004; Gomes et al., 2013). BigLEN 270 
and VIP are neuropeptides with multiple physiological effects, including gut motility, nutrient absorption, food 271 
intake regulation and immune responses (Yoo and Mazmanian, 2017). VIPR2 expression on intestinal innate 272 
lymphoid cells was shown to regulate their immune response (Seillet et al., 2020; Talbot et al., 2020). In 273 
addition, we also found that T-IEL express GLP1R and GLP2R (Figure 6b), receptors for the glucagon-like 274 
peptides 1 and 2 (GLP1 and GLP2), which are intestinal peptides involved in regulating appetite and satiety. 275 
Both of these receptors were previously mainly found on enteroendocrine cells and enteric neurons. 276 
However, recently GLP1R expression on T-IEL was shown to contribute to metabolic syndrome development 277 
in mice (He et al., 2019; Yusta et al., 2015). Together, these data suggest that T-IEL may be involved in 278 
regulating immune responses and potentially also metabolic responses to food intake through their 279 
communication with epithelial cells.  280 
T-IEL share a common signature with exhausted T cells 281 
T-IEL also express many signalling receptors that are absent on naïve T cells and that potentially regulate 282 
their poised activated state (Vandereyken et al., 2020). The proteomic analyses here confirmed that all 3 T-283 
IEL subsets express many inhibitory receptors, including LAG-3, CD200R1, CD244 and NK receptors, such 284 
as members of the Ly49 family, but also showed that a wider range of these inhibitory receptors are found on 285 
innate T-IEL compared to induced T-IEL (Figure 6b). Furthermore, T-IEL, regardless of ontogeny, uniformly 286 
expressed CD38 and CD73 (Nt5e) (Figures 6b,d). Indeed, co-expression of CD38 and CD73 is seen to 287 
provide a better marker for identifying T-IEL than CD103 expression (Figure 7a,b). These receptors are 288 
tightly linked to purinergic signalling through their regulation of P2RX7, and as previously found on TRM cells 289 
(Borges da Silva et al., 2018; Stark et al., 2018), P2RX7 and CD39 are also highly expressed on T-IEL, 290 
although less uniformly than CD38 and CD73 (Figure 7a,b).  291 
CD38 and CD39 have recently been identified as markers of T cell exhaustion, along with expression of PD-292 
1, LAG-3, CD244, CD160 among other inhibitory receptors. As all these molecules are highly expressed on 293 
T-IEL (Figure 7a-d), with the exception of PD-1, T-IEL appear to share some similarities with exhausted T 294 
cells (Alfei et al., 2019; Khan et al., 2019; Scott et al., 2019). An overrepresentation analysis using a 295 
database of T cell exhaustion markers confirmed that T IEL are enriched in markers of exhaustion (Figure 296 
7e), with at least 76 proteins that were upregulated in exhausted T cells also being upregulated in T-IEL 297 
(Figure 7f, top and Supplementary File 5). During exhaustion of systemic T cells, several proteins are 298 
downregulated. Interestingly, a significant proportion of these downregulated proteins are also 299 
downregulated in induced T-IEL (Figure 7f, bottom and Supplementary File 5). We therefore further 300 
examined the expression of transcription factors associated with T cell exhaustion (Figure 7g). Indeed, two 301 
transcription factors recently identified to be key to imprinting the ‘exhausted’ T cell phenotype, i.e., TOX and 302 
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NR4A2, were preferentially expressed in all T-IEL, whereas other transcription factors that show reduced 303 
expression in exhausted T cells, including TCF1 and LEF1, were also downregulated in T-IEL. We further 304 
confirmed expression of TOX in all T-IEL subsets by flow cytometry (Figure 7h). However, T-IEL still 305 
express high levels of T-bet, as do effector T cells, which most likely helps to maintain expression of cytolytic 306 
effector molecules, such as granzymes, while repressing PD-1 expression on T-IEL. Overall, both natural 307 
and induced T-IEL appear to have a hybrid phenotype combining features of exhausted T cells and effector 308 
T cells, while also bearing unique hallmarks imprinted by the intestinal microenvironment. 309 
Modifications in the T cell antigen receptor signalosome in T-IEL 310 
Given the connection between T-IEL and exhausted T cells, one key question we wanted to address was 311 
whether T-IEL are also unresponsive to TCR stimulation. Indeed, we find that only a small percentage 312 
(<10%) of both natural T-IEL subsets are able to respond to TCR crosslinking as measured by induction of 313 
phosphorylation of ERK1/2 and S6 ribosomal protein (Figure 8a,b). However, induced TCRαβ CD8αβ T-IEL 314 
responded even better than LN T cells to TCR stimulation. It has previously been recognised that cross-315 
linking of the TCR on TCRγδ T-IEL does not induce calcium flux and downstream signalling (Malinarich et 316 
al., 2010; Wencker et al., 2014). This reduced TCR signalling capacity has been attributed to chronic TCR 317 
signalling in the tissue. However, how TCR signalling is dampened at a mechanistic level has not yet been 318 
addressed. We sought to evaluate whether there were changes in the TCR signalosome in T-IEL that were 319 
blocking TCR signals, and how conserved it was across the different subsets (Figure 8c). Strikingly, several 320 
proteins were differentially expressed, not just in TCRγδ T-IEL, but in all T-IEL subsets including induced 321 
TCRαβ CD8αβ T-IEL. Quantitative analysis of the immediate TCR signalling elements confirmed previous 322 
studies showing exclusive expression of FcεR1γ and LAT2 (NTAL/LAB) on T-IEL, and downregulation of 323 
LAT and CD3ζ as compared to LN T cells (Figure 8c). Replacement of the CD3ζ chain with the FcεR1γ 324 
chain reduces the number of immunoreceptor tyrosine-based activation motifs (ITAMs) in the TCR. LAT2 is 325 
reported to play a dominant negative role in TCR signalling by competing with LAT for binding partners, but 326 
is unable to couple to PLCγ (Fuller et al., 2011).  327 
In addition to LAT and CD3ζ, several other proteins were differentially expressed (Figure 8c,d). Surprisingly, 328 
many proteins normally found in B cells and involved in BCR signal transduction, were identified as 329 
expressed in T-IEL, e.g., Lyn, Syk, LAT2, PLCγ2, Themis2, and many of these are also often found in 330 
exhausted T cells (Supplementary File 5, (Khan et al., 2019; Schietinger et al., 2016)). We also noted the 331 
expression of several negative regulators of TCR signalling, including STS-1 (Ubash3b) that 332 
dephosphorylates Zap70/Syk, CD148 (PTPRJ) and DUSP6, which negatively regulates MAPK signalling 333 
(Gaud et al., 2018) (Figure 8c,d). These negative regulators of signalling are also highly expressed in 334 
tumour-associated exhausted T cells (Schietinger et al., 2016). Conversely, key TCR signalling 335 
intermediates, such as Protein kinase C θ (PKCθ) and Rac were very poorly expressed. Importantly, many of 336 
these changes were not confined to the natural CD8αα T-IEL subsets but were also identified in induced T-337 
IEL.  338 
In summary, these data suggest that the rewiring of the TCR signalosome in T-IEL occurs independently of 339 
the developmental pathway through which the 3 different subsets are derived, and is instead shaped by the 340 
intestinal environment. However, as induced T-IEL also express LAT2 and FcεR1γ chain, but still respond to 341 
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TCR signals, the loss of TCR responsiveness in natural T-IEL cannot be solely attributed to these proteins. 342 
Further evaluation of the TCR signalling pathways is necessary to provide an explanation for the loss of TCR 343 
responses in natural T-IEL.  344 
Discussion 345 
Both TCRγδ and TCRαβ CD8αα natural T-IEL have long been considered unconventional T cells, due to 346 
their unique developmental pathways and their strict restriction to the intestinal epithelium. In contrast, 347 
induced T-IEL that arise from systemic antigen-experienced T cells, are considered conventional and more 348 
like memory T cells in their ability to respond rapidly to activation signals. Yet our unbiased analyses clearly 349 
show that induced T-IEL share far greater similarity to other intestinal T cell subsets than to the systemic T 350 
cells they arise from. The T-IEL signature most strikingly contains several proteins thought to be exclusively, 351 
or very highly, expressed by enterocytes. These include cognate proteins involved in mediating adherens 352 
and tight junction formation, showing that T-IEL are strongly integrated into the intestinal epithelium, by 353 
interactions that extend well beyond the CD103: E-cadherin interaction. T-IEL also share metabolic 354 
similarities with enterocytes including a strong enrichment in proteins required for cholesterol, lipid and 355 
xenobiotic metabolism. Many of these genes are aryl hydrocarbon receptor (AHR) targets (Stockinger et al., 356 
2014; Tanos et al., 2012), suggesting that one reason why AHR is essential for T-IEL survival (Li et al., 357 
2011) is to protect them from toxins and bacterial metabolites in the gut. Other potential indicators of tissue 358 
adaptation include expression of the intestine-specific GLUT2 glucose transporter, and the high expression 359 
of the urea cycle that could be important for detoxifying the large quantities of ammonia that is present in the 360 
intestinal lumen (Romero-Gomez et al., 2009). Furthermore, we find that despite having very low energy 361 
requirements, T-IEL have a distinct metabolic signature, with high expression of proteins such as GLUT3, 362 
glycerol-3-phosphate shuttle and peroxisomal FAO enzymes. Interestingly, the glycerol phosphate shuttle is 363 
normally only expressed in highly glycolytic cells to maintain cellular redox balance by recycling NAD in the 364 
cytosol, with most other mammalian cells using the malate-aspartate shuttle for this purpose (Mráček et al., 365 
2013, p.; Spinelli and Haigis, 2018). Thus, we find that T-IEL, far from being metabolically quiescent, have 366 
instead a metabolism tailored to their environment, to protect T-IEL from the harsh intestinal environment 367 
and actively limit proliferation and activation of these cells.   368 
Ribosomal content was the one area where T-IEL seemed truly deficient in comparison to naïve LN T cells. 369 
This was surprising, since naïve T cells, like T-IEL, are not actively cycling cells. However, it was recently 370 
shown that a subset of proteins in naïve T cells have short half-lives and are rapidly turned over (Wolf et al., 371 
2020). These included transcription factors that maintain the naïve state, but that need to be rapidly 372 
degraded upon T cell activation, allowing T cells to differentiate. Naïve T cells were also found to express a 373 
large number of idling ribosomes ready to translate mRNAs required for T cell activation. Thus, the non-374 
existent ribosomal activity in T-IEL subsets is possibly a reflection of their terminally differentiated status. It is 375 
also interesting to note that amino acid transporters were expressed at very low levels in T-IEL, thus limiting 376 
amino acid availability for protein translation. In this context, we recently showed that activation of T-IEL with 377 
IL-15 involves both upregulation of ribosome biogenesis and upregulation of amino acid transporters (James 378 
et al., 2020). The low rates of protein translation also highlight the importance of studying the proteome in T-379 
IEL as there may be a significant disconnect between protein and mRNA expression.  380 
   
 
   
 
12 
In identifying proteins that were expressed solely in T-IEL, but not LN T cells, we uncovered a clear signature 381 
of T cell exhaustion within the proteome. Like exhausted T cells, T-IEL have diminished capacity to 382 
proliferate in response to TCR triggering, and increased expression of co-inhibitory molecules. However, 383 
unlike exhausted T cells, T-IEL maintain high levels of cytotoxic effector molecules, suggesting that they are 384 
still capable of killing, although it is unclear what signals are required to trigger full degranulation in T-IEL. 385 
Interestingly, despite identifying more than 30 cell surface proteins on T-IEL that were not expressed in LN T 386 
cells, no one marker was exclusive to T-IEL, as they were either proteins that were normally expressed in 387 
intestinal epithelial cells, or those expressed on activated or exhausted T cells. Thus, the proteomic profiles 388 
of T-IEL reveal an interesting mixture of various T cell types; naïve, effector and exhausted, as well their 389 
unique tissue-specific signatures. 390 
T-IEL also display several hallmarks of exhausted or suppressed T cells, including a major rewiring of the 391 
TCR signalosome. We were surprised to find that LAT2, and many negative regulators of signalling, such as 392 
DUSP6 were also expressed in induced T-IEL. These data suggest that the changes in the TCR 393 
signalosome are induced by the gut environment, rather than being developmentally regulated. In addition, 394 
we found that all T-IEL express ACAT2, a key protein involved in cholesterol esterification, that potentially 395 
sequesters cholesterol away from the plasma membrane. Previously, ACAT1, but not the closely related 396 
ACAT2, was found to be upregulated in activated CD8
+
 T cells (Yang et al., 2016). Genetic ablation of 397 
ACAT1 lead to increased response from activated T cells in both infection and in cancer, and this was 398 
attributed to the increased cholesterol in the plasma membrane leading to increased TCR clustering (Molnár 399 
et al., 2012; Yang et al., 2016). Indeed, increased cholesterol content has also been shown to potentiate γδ 400 
T cell activation (Cheng et al., 2013). It would be interesting to see if the high levels of ACAT2 expressed in 401 
T-IEL prevent accumulation of cholesterol in the T-IEL membranes, thus increasing the activation threshold 402 
of T-IEL. On a similar note, ARG2, which was highly expressed in T-IEL, has also been shown to block T cell 403 
activation (Geiger et al., 2016; Martí i Líndez et al., 2019), and expression of the alanine metabolizing 404 
enzyme, GPT1, may limit alanine availability for protein synthesis in T cell activation (Ron-Harel et al., 2019). 405 
Thus, multiple lines of evidence support the notion that both natural and induced T-IEL are tightly regulated 406 
through inhibition of signalling.  407 
In summary, we have presented an in-depth proteomic analyses and comparisons of induced and natural T-408 
IEL and systemic T cells. These data provide key insights into the nature of T-IEL as well as the 409 
underappreciated similarities between both induced and natural T-IEL. New findings related to cholesterol 410 
metabolism, a high energy and translation barrier to activation, and transcription factors that potentially 411 
regulate T-IEL function, suggest new ways to investigate how the different T-IEL subsets contribute to tissue 412 
and organismal homeostasis.  413 
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 424 
Mice 425 
All mice were bred and maintained with approval by the University of Dundee ethical review committee in 426 
compliance with U.K. Home Office Animals (Scientific Procedures) Act 1986 guidelines. C57BL/6J mice were 427 
purchased from Charles Rivers and acclimatised for a minimum of 10 days prior to use in experiments. Mice 428 
were maintained in a standard barrier facility on a 12hour light/dark cycle at 21ºC, 45-65% relative humidity, 429 
in individually ventilated cages with corn cob and sizzler-nest material and fed an R&M3 diet (Special Diet 430 
Services, UK) and filtered water ad libitum. Cages were changed at least every two weeks. For all 431 
experiments mice were used between 8-12 weeks of age, and for proteomics, male mice aged 8-9 weeks 432 
were used.  433 
 434 
T-IEL and LN CD8 T cell isolation 435 
T-IEL were isolated for sorting from mice and as described in (James et al., 2020). Briefly, small intestines 436 
were extracted and flushed. Small intestines were longitudinally opened, then transversely cut into ~5 mm 437 
pieces and put into warm media containing 1mM DTT. Small intestine pieces were shaken for 40min, 438 
centrifuged, vortexed and passed through a 100μm sieve. The flow-through was centrifuged on a 36%/67% 439 
Percoll density gradient at 700g for 30 minutes. The T-ΙEL were isolated from the interface between 36% and 440 
67% Percoll. In some experiments, isolated T-IEL were further enriched using an EasySep™ Mouse CD8α 441 
positive selection kit (STEMCELL Technologies) as per the manufacturer’s instructions. Isolation and sorting 442 
details for the LN and effector populations used for proteomics can be found at www.Immpres.co.uk under 443 
the ‘Protocols & publications’ tab.  444 
 445 
Proteomics sample preparation and peptide fractionation 446 
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Sample preparation was done as in (Howden et al., 2019). Briefly, cell pellets were lysed, boiled and 447 
sonicated, and proteins purified using the SP3 method (Hughes et al., 2014). Proteins were digested with 448 
LysC and Trypsin and TMT labelling and peptide clean-up performed according to the SP3 protocol. The 449 
TMT labelling set up is available in Supplementary File 6. The TMT samples were fractionated using off-line 450 
high-pH reverse-phase chromatography: samples were loaded onto a 4.6 mm × 250 mm Xbridge BEH130 451 
C18 column with 3.5 μm particles (Waters). Using a Dionex BioRS system, the samples were separated 452 
using a 25-min multistep gradient of solvents A (10 mM formate at pH 9 in 2% acetonitrile) and B (10 mM 453 
ammonium formate at pH 9 in 80% acetonitrile), at a flow rate of 1 ml min
−1
. Peptides were separated into 48 454 
fractions, which were consolidated into 24 fractions. The fractions were subsequently dried, and the peptides 455 
were dissolved in 5% formic acid and analysed by liquid chromatography–mass spectrometry. 456 
 457 
Liquid chromatography electrospray–tandem mass spectrometry analysis 458 
For each fraction, 1 μg was analysed using an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher 459 
Scientific) equipped with a Dionex ultra-high-pressure liquid chromatography system (RSLCnano). 460 
Reversed-phase liquid chromatography was performed using a Dionex RSLCnano high-performance liquid 461 
chromatography system (Thermo Fisher Scientific). Peptides were injected onto a 75 μm × 2 cm PepMap-462 
C18 pre-column and resolved on a 75 μm × 50 cm RP C18 EASY-Spray temperature-controlled integrated 463 
column-emitter (Thermo Fisher Scientific) using a 4-h multistep gradient from 5% B to 35% B with a constant 464 
flow of 200 nl min
−1
. The mobile phases were: 2% acetonitrile incorporating 0.1% formic acid (solvent A) and 465 
80% acetonitrile incorporating 0.1% formic acid (solvent B). The spray was initiated by applying 2.5 kV to the 466 
EASY-Spray emitter, and the data were acquired under the control of Xcalibur software in a data-dependent 467 
mode using the top speed and 4 s duration per cycle. The survey scan was acquired in the Orbitrap covering 468 
the m/z range from 400–1,400 Thomson units (Th), with a mass resolution of 120,000 and an automatic gain 469 
control (AGC) target of 2.0 × 10
5
 ions. The most intense ions were selected for fragmentation using collision-470 
induced dissociation in the ion trap with 30% collision-induced dissociation energy and an isolation window 471 
of 1.6 Th. The AGC target was set to 1.0 × 10
4
, with a maximum injection time of 70 ms and a dynamic 472 
exclusion of 80 s. During the MS3 analysis for more accurate TMT quantifications, ten fragment ions were 473 
co-isolated using synchronous precursor selection, a window of 2 Th and further fragmented using a higher-474 
energy collisional dissociation energy of 55%. The fragments were then analysed in the Orbitrap with a 475 
resolution of 60,000. The AGC target was set to 1.0 × 10
5
 and the maximum injection time was set to 300 ms. 476 
 477 
MaxQuant processing 478 
The raw proteomics data were analysed with MaxQuant (v. 1.6.3.3) (Cox and Mann, 2008; Tyanova et al., 479 
2016) and searched against a hybrid database. The database contained all murine SwissProt entries, along 480 
with TrEMBL entries with a human paralog annotated within human SwissProt and with protein level 481 
evidence. The data was searched with the following modifications: carbamidomethylation of cysteine, as well 482 
as TMT modification on peptide amino termini and lysine side chains as fixed modifications; methionine 483 
oxidation and acetylation of amino termini of proteins were variable modifications. The false discovery rate 484 
was set to 1% at the protein and PSM level.  485 
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Protein and BioReplicate filtering 486 
Proteins groups marked as ‘Contaminants’, ‘Reverse’ or ‘Only identified by site’ were filtered out. 487 
Additionally, proteins detected with less than 2 unique and razor peptides were also filtered out. 488 
Within both the TCRαβ CD8αα and TCRαβ CD8αβ T-IEL one replicate (replicate 4) was filtered out from the 489 
downstream analysis due to protein content discrepancies. This biorep displayed a 15% reduction in protein 490 
content compared to the other 3 replicates within the TCRγδ CD8αα and an increase in protein content of 491 
32% when compared to the remaining 3 replicates within the TCRαβ CD8αβ. 492 
 493 
Protein copy numbers and protein content 494 
Protein copy number were estimated from the MS data using the proteomic ruler (Wisniewski et al., 2014) 495 
after allocating the summed MS1 intensities to the different experimental conditions according to their 496 
fractional MS3 reporter intensities. The protein content was calculated based on copy numbers. The 497 
molecular weight (in Da) of each protein was multiplied by the number of copies for the corresponding 498 
protein and then divided by NA (Avogadro’s Constant) to yield the individual protein mass in g cell
-1
. The 499 
individual masses were converted into picograms and then summed for all proteins to calculate the protein 500 
content. 501 
 502 
Differential expression and overrepresentation analyses 503 
All fold-changes and P-values for the individual proteins were calculated in R utilising the bioconductor 504 
package LIMMA  version 3.7. The Q-values provided were generated in R using the “qvalue” package 505 
version 2.10.0. All other p-values were calculated using Welch’s T-test. For all overrepresentation analyses 506 
(ORA) the background was set to the subset of proteins which were identified in either TCRαβ CD8αβ T- IEL 507 
or in LN TCRαβ CD8αβ T cells. The Gene Ontology ORAs were done using DAVID (Jiao et al., 2012) and 508 
PANTHER (Mi et al., 2019). Two distinct analyses were performed, one for proteins with a p-value <0.001 509 
and fold change greater than or equal to the median plus 1.5 standard deviations and a second one for 510 
proteins with a p-value <0.001 and fold change smaller than or equal to the median minus 1.5 standard 511 
deviations. The exhaustion ORA was done using WebGestalt (Wang et al., 2017) using the exhaustion 512 
markers provided reported within the literature (Khan et al., 2019) as a functional database for the analysis. 513 
Statistical significance thresholds 514 
For the bar and box plots, symbols on bars represent independent biological replicates. For the mass 515 
spectrometry derived bar plots and heatmaps ;  **= p-value<0.001 and fold change greater than or equal to 516 
the median plus 1 standard deviation, ***= p-value <0.0001 and fold change greater than or equal to the 517 
median +/- 1.5 standard deviations, based on the differential expression analyses described above. For all 518 
plots with non-MS based data, statistical analyses were carried out using R and GraphPad Prism v.8. The 519 
exact tests used are described in the figure legends, and p-values <0.05 were considered significant. 520 
Flow cytometry 521 
Cells were stained with titrated concentrations of the following murine monoclonal antibodies: TCRβ [clone 522 
H57-597 (BioLegend)], TCRγδ [clone GL3 (BioLegend or eBioscience)], CD4 [clone RM4-5 (BioLegend)], 523 
CD8α [clone 53-6.7 (BioLegend)], CD8β [clone H35-17.2 (eBioscience)], CD103 [clone 2E7 (BioLegend)], 524 
CD39 [clone Duha59 (BioLegend)], CD73 [clone Ty/11.8 (BioLegend)], CD38 [clone 90 (BioLegend)], P2X7R 525 
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[clone 1F11 (BioLegend)], CD244 [clone eBio244F4 (eBioscience)], LAG-3 [(clone eBioC9B7W)], CD160 526 
[clone 7H1 (BioLegend)], CD96 [clone 3.3 (BioLegend)], EpCAM [clone G8.8 (eBioscience)], E-Cadherin 527 
[clone DECMA-1 (eBioscience)], TOX [clone TXRX10 (eBioscience)]. All data was acquired on a LSR 528 
Fortessa flow cytometer with DIVA software (BD Biosciences). Data were analysed using FlowJo software 529 
v10 (TreeStar). 530 
For TCR stimulation, T-IEL and LN T cells were isolated and enriched for CD8+ as described above. T-IEL 531 
were stained with Live/Dead fixable Near-IR (ThermoFisher) (1:250) for 10 min prior to stimulation then 532 
combined with LN T cells at a 1:1 ratio and resuspended at a concentration of 10
6
 cells/ml in RPMI 533 
containing 1% FBS, L-Glutamine and Penicillin/Streptomycin. Cells were warmed at 37°C before being 534 
stimulated with 30μg/ml of anti-CD3 antibody [clone 145-2C11 (BioLegend)] and 5μg/ml of polyclonal anti-535 
hamster crosslinking antibody (Jackson ImmunoResearch) for 5 min at 37°C. For some samples as 536 
indicated, PP2 was added at a concentration of 20μM for 1 hour prior to stimulation. After stimulation cells 537 
were directly fixed in 2% PFA 10 min at 37°C before permeabilization with 90% ice cold methanol. Samples 538 
were then fluorescently barcoded with different concentration (0, 11.1, 33.3 or 100μg/ml) of the Pacific Blue 539 
Dye (ThermoFisher) for 40 min, on ice before quenching with PBS+ 0.5% BSA (v:v). Barcoded samples were 540 
then pooled and stained for intracellular phospho-proteins, phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) 541 
[Clone 197G2 (Cell Signalling Technologies)] and phospho-S6 ribosomal protein (Ser235/236) [Clone 542 
D57.2.2E (Cell Signalling Technologies)] for 30 min at RT, protected from light, followed by secondary 543 
DyLight649 antibody (BioLegend). Cells were then stained for surface markers. Data were acquired using 544 
CytoFlex flow cytometer and analysed using FlowJo software (v10). Data were analysed using the “Forward 545 
deconvolution method” described in (Krutzik and Nolan, 2006). Briefly, samples were differentiated based in 546 
the fluorescence intensities of each dye and then individual samples were analysed for their respective 547 
phospho-protein expression. 548 
 549 
Protein synthesis measurements 550 
For comparing rates of protein synthesis, T-IEL and LN single cell suspensions were cultured with 20µM O-551 
propargyl-puromycin (OPP) (JenaBioscience) for 15 minutes. As a negative control, cells were pre-treated 552 
with 0.1mg/mL cycloheximide (CHX) for 15 minutes before adding the OPP for 15 minutes (30m total CHX 553 
exposure). Cells were then harvested, fixed with 4% paraformaldehyde (PFA) and permeabilised with 0.5 % 554 
triton X-100 before undergoing a copper catalysed click chemistry reaction with Alexa 647-azide (Sigma). 555 
Following surface marker staining, cells were resuspended in PBS + 1% BSA and analysed by flow 556 
cytometry to determine the degree of incorporation of OPP. All samples were acquired on a LSR Fortessa 557 
flow cytometer with DIVA software (BD Biosciences). Data were analysed using FlowJo software. 558 
Cellular cholesterol measurements 559 
Cholesterol content was measured using the Amplex Red cholesterol Assay Kit (Invitrogen). T-IEL were 560 
sorted into TCRβ+CD8αα+, TCRβ+CD8αβ+ and TCRγδ+CD8αα+ populations and LN cells were sorted for 561 
TCRβ+CD8αβ CD44-lo CD62L-hi cells using the BD Influx Cell Sorter (BD Biosciences). Each population 562 
was lysed at a concentration of 10x10
6
 cells/ml in 1X Amplex Red reaction buffer (Invitrogen) for 10 minutes 563 
at 4°C then spun at 13,200 rpm for 12 minutes. Lysate was removed and diluted in 1X Amplex Red reaction 564 
buffer. 50 μl of 300 μM Amplex Red reagent (containing 2 U/ml horseradish peroxidase, 2 U/ml cholesterol 565 
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oxidase and 0.2 U/ml cholesterol esterase) was added to 50 μl of diluted lysate. The reaction was incubated 566 
for 30 minutes at 37°C in the dark before reading on the Clariostar microplate reader (BMG Labtech) at 567 
excitation wavelength of 530 nm and emission wavelength of 590nm. Cholesterol content in the lysates was 568 
calculated with reference to cholesterol standards.  569 
Immunofluorescence and imaging 570 
T-IEL and LN T cells were isolated and enriched for CD8+ as described above. T-IEL were then washed 571 
twice in RPMI/10%FBS-containing media and further depleted of contaminating dead cells using EasySep™ 572 
Dead Cell Removal (Annexin V) Kit (STEMCELL Technologies) as per manufacturer instructions, for 573 
negative enrichment of T-IEL. The purity and viability were checked by flow cytometry with CD8α-APC 574 
antibody and DAPI. LN CD8 T cells were at >98% purity, and the IEL were enriched to 60% purity.  575 
1x10
6
 lymphocytes in PBS were gravity-sedimented onto each 18 mm round coverslip (N1.5) as described 576 
(Tsang et al., 2017). Cell were fixed in 3.7% PFA in PBS, pH=7.4, for 10 min at room temperature, washed 577 
with PBS, permeabilised with 0.5% Triton X-100 in PBS for 15 min, washed with PBS and blocked with 2% 578 
bovine serum albumin and 0.1% Triton X-100 in PBS for 45 min prior to staining with primary antibodies 579 
diluted as indicated below in blocking solution, or blocking solution alone, for 1h 45 min at room temperature. 580 
Antibodies used were polyclonal rabbit anti-ZO-2 (Cell Signalling Technologies) used at 1:50 dilution, mouse 581 
monoclonal anti-E-cadherin  (BD Biosciences), used at 1:100 dilution, rat monoclonal  anti-CD8α-FITC [clone 582 
53-6.7, (Biolegend), used at 1:100]. After three washes with PBS cells were further incubated with 583 
appropriate secondary antibodies diluted 1:500 in blocking solution for 1 h.  Secondary antibodies used were 584 
goat anti-rat-AlexaFluor488 (Invitrogen); goat anti-mouse-AlexaFluor568 (Invitrogen); donkey anti-rabbit-585 
AlexaFluor647 (Jackson ImmunoResearch). After additional 3 washes with PBS cells were stained with 1 586 
µg/ml DAPI in PBS for 10-15 min, washed with PBS and mounted onto glass slides using ProLong gold 587 
antifade reagent (Thermo Fisher Scientific) as a mounting media. Stained cells were imaged using LSM 710 588 
confocal microscope operated by Zen software (Zeiss) with a 63x/1.4NA oil immersion objective. For each 589 
image, 7-12 optical sections spanning the entire thickness of the cells were collected. The maximal intensity 590 
projections were generated and intensities adjusted in identical manner for all images in OMERO using the 591 
OMERO.figure app (Allan et al., 2012). 592 
Data availability 593 
The raw and processed mass spectrometry proteomics data have been deposited to the ProteomeXchange 594 
Consortium via the PRIDE partner repository (Perez-Riverol et al., 2019) with the dataset identifier 595 
PXD023140 (https://www.ebi.ac.uk/pride/archive/projects/PXD023140/). All other data generated in this 596 
study are included within the manuscript and supporting files. 597 
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Figure 1: Quantitative proteomic analyses of induced and natural T-IEL subsets  805 
(a) Schematic of the MS based proteomics workflow. The data were acquired at the MS3 level with 806 
synchronous precursor selection (see methods). (b) Principal component analysis comparing the TMT based 807 
estimated protein copy numbers of conventional naive and effector T cells with T-IEL. CTL, Cytotoxic T 808 
lymphocytes. (c) Bar plot showing the number of proteins identified across all replicates in the 5 populations 809 
used for this study. (d) Box plot showing the MS based protein content estimation for all replicates used 810 
across the 5 populations. (e) Principal component analysis comparing the estimated protein copy numbers 811 
across conventional naïve LN T cells and T-IEL subsets. (f-i) Scatter plot comparing the estimated copy 812 





















 T-IEL, (i) WT LN TCRαβ CD8αβ T 814 
cells and p14 LN TCRαβ CD8αβ T cells. Pearson correlation coefficient are included within all the scatter 815 
plots. The proteomics data displayed on the plots include CTL (n=3 biological replicates), conventional naïve 816 








 T-IEL 817 




 T-IEL (n= 4 biological replicates). For boxplots, the bottom 818 




 quartiles. The top whisker extends from the hinge to the largest 819 
value no further than 1.5 × IQR from the hinge; the bottom whisker extends from the hinge to the smallest 820 
value at most 1.5 × IQR of the hinge. The bar plots show the mean. Total number of proteins identified and 821 
total protein content across all populations are available in Figure 1-source data 1. 822 
Figure 1- source data 1: Total protein identifications and total protein content across all populations 823 
Figure 1- figure supplement 1. Gating strategy used to identify and isolate T-IEL subsets using 824 
fluorescence activated cell sorting (FACS). Lymphocytes were gated by size using forward scatter (FCS) 825 
and side scatter (SSC) and T-IEL subsets were separated based on the cell surface marker expression of T 826 
cell-associated receptors: TCRβ, TCRγδ, CD8α, CD8β and CD4. The populations sorted were as followed: 827 
cells positive for TCRγδ and CD8αα (TCRγδ CD8αα T-IEL), and those that were both TCRβ+ and CD4- and 828 
either CD8αα (TCRβ CD8αα T-IEL) or CD8β (TCRβ CD8αβ T-IEL). 829 
Figure 2: Gene ontology analyses of the induced T-IEL proteome 830 
(a) Treemap showing the abundance of proteins classified into histones, ribosomal proteins, cytoskeletal 831 




 T-IEL. Rectangle size is proportional to the median estimated copy numbers. Median copy numbers 833 
across all categories are available in Figure 2-source data 1. (b) Bar plots showing the estimated copy 834 
numbers for all granzymes across WT LN TCRαβ CD8αβ T cells (n=6) and all T-IEL (n=3 or 4). Symbols on 835 
the bars represent the biological replicates. The bars show the mean and SEM. p-values have been 836 
calculated on R with LIMMA where **= p <0.001 and fold change greater than or equal to the median plus 1 837 
standard deviation, ***= p <0.0001 and fold change greater than or equal to the median +/- 1.5 standard 838 
deviations. (c) Bar plot showing the results of the DAVID functional annotation clustering (FDR<0.05; see 839 





 T-IEL. (d) Bar plot showing the results of the PANTHER GO Biological process 841 
(FDR<0.05; see methods for details) enrichment analysis for all proteins exclusive to or significantly 842 




 T-IEL (blue) or within WT TCRαβ CD8αβ T cells (red).  843 
   
 
   
 
27 
Figure 2-source data 1: Median copy numbers for the global analysis 844 
Figure 3: Downregulation of protein synthesis in T-IEL 845 
(a) Box plots showing the estimated total cytoplasmic (left) and mitochondrial (right) ribosomal protein copies 846 
for LN TCRβ CD8αβ T cells and all T-IEL subsets. The sums of all copy numbers are available in Figure 3-847 
source data 1. (b) Box plots showing the estimated summed total protein copies for the protein subunits that 848 
are exclusive to RNA Polymerases I, II and III, respectively for LN TCRβ CD8αβ T cells and all T-IEL 849 
subsets. The sum of all copy numbers are available in Figure 3-source data 1. (c) Bar plots showing the 850 
estimated protein copy numbers of the amino acid transporters, SLC7A5 and SLC38A2, for WT LN TCRβ 851 
CD8αβ and all 3 subsets of T-IEL. (d) Bar plots showing the estimated protein copy numbers of Arginase 2 852 
(ARG2; left) and alanine aminotransferase (GPT; right) for WT LN TCRβ CD8αβ and all 3 subsets of T-IEL. 853 
(e) Bar plots showing the estimated protein copy numbers of PRKR-Like Endoplasmic Reticulum 854 
Kinase (PERK) for WT LN TCRβ CD8αβ and all 3 T-IEL subsets. (f) Bar plots showing the OP-Puromycin 855 
(OPP) incorporation (n= 3 biological replicates) in ex vivo WT LN TCRβ CD8αβ and T-IEL. As a negative 856 
control, OPP incorporation was inhibited by cycloheximide (CHX) pre-treatment. OPP incorporation was 857 
assessed by flow cytometry 15 min after administration. Bar graph represents the geometric MFI of the OPP-858 
AlexaFluor 647 in each T cell subsets normalized to the geometric MFI of the CHX pre-treated T cells. p-859 
values were calculated using ordinary one-way ANOVA with Dunnett’s multiple comparisons. For all box 860 




 quartiles. The top whisker extends from the hinge 861 
to the largest value no further than 1.5 × IQR from the hinge; the bottom whisker extends from the hinge to 862 
the smallest value at most 1.5 × IQR of the hinge. All bar plots show the mean and SEM. Symbols on the 863 
bars represent the biological replicates. The proteomics data displayed on the plots include WT TCRαβ 864 













 T-IEL (n= 4 biological replicates). The P-values for individual proteins (c,d,e) 866 
were calculated in R with LIMMA, where **= p <0.001 and fold change greater than or equal to the median 867 
plus 1 standard deviation, ***= p <0.0001 and fold change greater than or equal to the median +/- 1.5 868 
standard deviations, and in (a,b) in R with Welch’s T test. 869 
Figure 3-source data 1: Sum of median copy numbers for the cytoplasmic and mitochondrial 870 
ribosomes 871 
Figure 3- figure supplement 1: (a) Box plots showing the median Log2 fold change (T-IEL/LN CD8 T cells) 872 
for RNA Polymerase 1, 2 and 3 complexes. Each grey dot represents one of the polymerase subunits. P-873 
values were calculated using one-sample t-tests, where *= p<0.05, **=p<0.01, ***=p<0.001, ns= not 874 
significant. (b) Schematic representation of the urea cycle. Coloured heatmap squares represent protein 875 
expression Log2 fold change (T-IEL/LN CD8 T cells) in, from left to right, T-IEL TCRβ CD8αβ, T-IEL TCRβ 876 
CD8αα and T-IEL TCRγδ CD8αα. Proteins expressed only by T-IEL are highlighted by red squares, 877 
representing estimated protein copy numbers (mean from at least 3 biological replicates). For protein names, 878 
see supplementary Table 4. 879 
Figure 4: Metabolic profiling of the T-IEL proteome 880 
(a) Stacked bar plots comparing the proportional representation of metabolic pathways in LN TCRβ CD8αβ 881 
and all T-IEL subsets. (b) Bar plots showing the estimated protein copy numbers of the glucose transporters, 882 
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GLUT1, GLUT2 and GLUT3, for WT LN TCRβ CD8αβ and all 3 subsets of T-IEL. (c) Heatmaps displaying 883 
the Log2 fold change (T-IEL/ LN CD8 T cells) for all proteins involved in glycolysis, tricarboxylic acid cycle 884 
(TCA cycle) and fatty acid oxidation (FAO). (d) Bar plots showing the sum of the estimated protein copy 885 
numbers of the electron transporter chain (ETC) components, for WT LN TCRβ CD8αβ and all 3 subsets of 886 
T-IEL. Sum of the copy numbers across all ETC complexes are available in Figure 4-source data 1. (e) 887 
Schematic representation of the glycerol 3-phosphate shuttle with heatmaps showing protein expression of 888 
cytosolic glycerol-3-phosphate dehydrogenase (cGpDH) and the Log2 fold change of mitochondrial glycerol-889 
3-phosphate dehydrogenase (mGpDH) (T-IEL/LN CD8 T cells) in, from left to right, T-IEL TCRβ CD8αβ, T-890 
IEL TCRβ CD8αα and T-IEL TCRγδ CD8αα. All bar plots show the mean and SEM. Symbols on the bars 891 
represent the biological replicates. The proteomics data displayed on the plots include WT TCRαβ CD8αβ T 892 













 T-IEL (n= 4 biological replicates). P-values for individual proteins (b-c) were calculated 894 
in R with LIMMA, where **= p <0.001 and fold change greater than or equal to the median plus 1 standard 895 
deviation, ***= p <0.0001 and fold change greater than or equal to the median +/- 1.5 standard deviations, 896 
and in (d) in R with Welch’s T test. For full protein names, see Supplementary File 4. 897 
Figure 4-source data 1: Sum of median copy numbers for the all the ETC complexes 898 
 899 
Figure 5: T-IEL have enhanced cholesterol and lipid metabolism  900 
(a) Schematic representation of proteins involved of the cholesterol biosynthetic pathway. Heatmap squares 901 
represent the Log2 fold change (T-IEL/LN CD8 T cells) in, from left to right, T-IEL TCRβ CD8αβ, T-IEL TCRβ 902 
CD8αα and T-IEL TCRγδ CD8αα. Proteins expressed only by T-IEL are highlighted by red squares, 903 
representing the mean estimated protein copy numbers (from at least 3 biological replicates). (b) Bar plot 904 
showing the estimated protein copy number of SREBP2 for WT LN TCRβ CD8αβ and all 3 subsets of T-IEL. 905 
(c) Bar plot showing a comparison of total cellular cholesterol content in sorted WT LN TCRβ CD8αβ and all 906 
3 subsets of T-IEL (n=4 biological replicates). P-values calculated using ordinary one-way ANOVA with 907 
Dunnett’s multiple comparison test. Data for the total cholesterol content are available in Figure 5-source 908 
data 1. (d) Bar plots showing the estimated protein copy numbers of the fatty acid transporters FATP1, 909 
FATP2 and FATP4 for WT LN TCRβ CD8αβ and all 3 subsets of T-IEL. (e) Bar plots showing the estimated 910 
protein copy numbers of the fatty acid binding proteins FABP1, FABP2, FABP5 and FABP6 for WT LN TCRβ 911 
CD8αβ and all 3 subsets of T-IEL. (f) Schematic representation of the triacylglycerol synthesis pathways and 912 
lipoprotein assembly. Coloured squares represent the Log2 fold change (T-IEL/LN CD8 T cells) in, from left 913 
to right, T-IEL TCRβ CD8αβ, T-IEL TCRβ CD8αα and T-IEL TCRγδ CD8αα. Proteins expressed only by T-914 
IEL are highlighted by red squares, representing estimated protein copy numbers (mean from at least 3 915 
biological replicates).  916 
All bar plots show the mean and SEM. Symbols on the bars represent the biological replicates. The 917 













 T-IEL (n= 919 
4 biological replicates). P-values for individual proteins (a,b,d,e,f) were calculated in R with LIMMA, where 920 
**= p <0.001 and fold change greater than or equal to the median plus 1 standard deviation, ***= p <0.0001 921 
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and fold change greater than or equal to the median +/- 1.5 standard deviations. For full protein names, see 922 
Supplementary File 4. 923 
Figure 5-source data 1: Total cholesterol content across all populations 924 
 925 
Figure 6: Cell surface proteins expressed on T-IEL 926 
(a) Schematic representation of proteins involved in cell-cell adhesion that are only expressed by the 927 
different T-IEL subsets. (b) Heatmaps displaying the estimated protein copy numbers of adhesion molecules, 928 
co-signalling receptors, neuropeptide receptors and purinergic receptors expressed only by T-IEL. Data 929 
represent the mean of at least 3 biological replicates. (c) Purified LN CD8 T cells (left) and isolated T-IEL 930 
(right) were immunostained for ZO-2 (top, red), E-cadherin (bottom, green) and CD8α (not shown) and 931 
counterstained with DAPI to mark the nuclei (blue). Representative (of 2 independent experiments) maximal 932 
intensity projections of confocal sections spanning the entire cell thickness of selected CD8+ cells of each 933 
type are shown. Size bars = 2 µm. See also Supplementary Figure 3. (d) Heatmap displaying Log2 fold 934 
change (T-IEL/ LN CD8 T) cells of adhesion molecules, co-signalling receptors and purinergic receptors. The 935 
proteomics data displayed on the plots show the mean values and were calculated from WT TCRαβ CD8αβ 936 













 T-IEL (n= 4 biological replicates). P-values were calculated in R with 938 
LIMMA, where **= p <0.001 and fold change greater than or equal to the median plus 1 standard deviation, 939 
***= p <0.0001 and fold change greater than or equal to the median +/- 1.5 standard deviations. 940 
 941 
Figure 6- figure supplement 1: Expression of epithelial proteins in T-IEL. a) Bar plots showing the 942 
ImmGen microarray database (www.immgen.org) derived normalised RMA values for Tjp2 (ZO2), EpCam 943 
and Cdh1 (E-Cadherin) across WT naïve CD8 T cells (T.8Nve.Sp and T.8Nve.LN) and TCRγδ Vγ5-ve or 944 
Vγ5+ve IEL (Tg.dVg5-.IEL, TgdVg5+IEL) (b-c) Comparison, by flow cytometry of the expression of EpCam 945 
(b) and E-Cadherin (c) in WT LN CD8 T cells, all 3 subsets of T-IEL and intestinal epithelial cells (IEC). Bar 946 
plots presenting geometric mean fluorescence intensities of n=3 biological replicates are shown on the side 947 
of each histogram. Mean ± SEM shown. p-values were calculated using one-way ANOVA and Dunnett’s 948 
multiple comparisons test. (d) Gating strategy used to identify T-IEL and IEC for (b-c). Lymphocytes and IEC 949 
were gated by size using forward scatter (FCS) and side scatter (SSC) and doublets were excluded. T-IEL 950 
subsets were separated as described in the FACS sorting strategy in supplementary Figure 1. (e) ZO-2 and 951 
E-cadherin immunofluorescence of IEL and WT LN CD8 T cells. Isolated IEL depleted of Annexin V-positive 952 
contaminants (IEL, top) and isolated purified LN CD8 T cells (LN, bottom) were fixed, permeabilised, 953 
immunostained for ZO-2 (green on overlay, left panels), E-cadherin (red on overlay, left panels) and CD8α 954 
(not shown) or with secondary antibodies only (right panels), and counterstained with DAPI to mark the 955 
nuclei (blue). Representative maximal intensity projections of confocal sections spanning the entire cell 956 
thickness of CD8α-positive cells of each type are shown. Black and white images show individual ZO-2 957 
(middle rows) or E-cadherin (bottom rows) staining or matching secondary antibody-only controls. All images 958 
were acquired and processed identically. Size bars are 2 µm. 959 
 960 
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Figure 7: T-IEL share similarities with exhausted T cells 961 
(a) Flow cytometry dot plots comparing the expression of purinergic receptors (CD38/CD73, top and 962 
P2X7R/CD39, bottom) in WT LN TCRβ CD8αβ and all 3 subsets of T-IEL. (b) Stacked doughnut plot 963 
showing the percentages of cells from LN CD8 T cells and T-IEL expressing the indicated purinergic 964 
receptors, quantified by flow cytometry (n=1 biological replicate). (c) Flow cytometric histograms comparing 965 
the protein expression of the exhaustion markers, CD244, LAG-3, CD160 and CD96 in all 3 subsets of T-966 
IEL. (d) Stacked doughnut plot showing the percentage of cell from LN CD8 T cells and T-IEL expressing the 967 
indicated exhaustion markers quantified by flow cytometry (n= 4 biological replicates). (e) Bar plot showing 968 
the result of the T cells exhaustion overrepresentation analyses in LN TCRβ CD8αβ and in TCRβ CD8αβ T-969 
IEL. (f) Venn diagrams showing the commonality of proteins upregulated (top) and downregulated (bottom) 970 
during exhaustion and in TCRβ CD8αβ T-IEL. (g) Heatmap displaying the Log2 fold change (T-IEL/LN CD8 T 971 
cells) of transcription factors associated with exhaustion in T cells. (h) Bar plots showing the estimated 972 
protein copy number of TOX (left) and flow cytometry derived MFI for TOX (right) for WT LN TCRβ CD8αβ 973 
and all 3 subsets of T-IEL. The proteomics data displayed on the plots include WT TCRαβ CD8αβ T cells 974 













 T-IEL (n= 4 biological replicates). The flow cytometry was performed on 3 biological 976 
replicates, representative of 2 independent experiments. P-values for individual proteins (g-h) were 977 
calculated in R with LIMMA where **= p <0.001 and fold change greater than or equal to the median plus 1 978 
standard deviation, ***= p <0.0001 and fold change greater than or equal to the median +/- 1.5 standard 979 
deviations, for the flow cytometry data (h) in GraphPad prism using one-way ANOVA with Dunnett’s multiple 980 
comparisons test. For full protein names, see Supplementary File 4.  981 
Figure 7-source data 1: Flow cytometry-based percentage of cells expressing exhaustion markers 982 
and TOX MFI 983 
 984 
Figure 8: Rewiring of the TCR signalosome in T-IEL 985 
(a-b) Responses of WT LN CD8 T cells and T-IEL to TCR stimulation. Bar plots show the percentage of cells 986 
positive for (a) phospho-ERK1/2 (T202/Y204) and (b) phospho-S6 (S235/236) before and after anti-CD3 987 
stimulation. The Src kinase inhibitor PP2 was added as a control to show that induction of ERK1/2 and S6 988 
phosphorylation was specific. N=3 biological replicates, p-values were calculated by two-way ANOVA with 989 
Dunnett’s multiple comparisons test. Data are available in Figure 8-source data 1. (c-d) Schematic 990 
representation of the main TCR signalling pathways comparing the expression of selected proteins in T-IEL 991 
and LN naïve T cells. (c) TCR and LAT signalosome. (d) signalling pathways downstream TCR receptor. All 992 
heatmap squares represent the Log2 fold change (T-IEL/LN CD8 T cells) in, from left to right, T-IEL TCRβ 993 
CD8αβ, T-IEL TCRβ CD8αα and T-IEL TCRγδ CD8αα. Proteins expressed only by T-IEL are highlighted by 994 
red squares, representing estimated protein copy numbers (mean from at least 3 biological replicates). The 995 













 T-IEL (n= 4 biological replicates). P-values were calculated in R with LIMMA, where **= p <0.001 998 
and fold change greater than or equal to the median plus 1 standard deviation, ***= p <0.0001 and fold 999 
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change greater than or equal to the median +/- 1.5 standard deviations. For protein names, see 1000 
Supplementary File 4. 1001 
Figure 8-source data 1: Flow cytometry-based percentage of cells positive for Phospho ERK1/2 and 1002 
phospho S6  1003 
 1004 
Supplementary File 1: Estimated protein copy numbers and differential expression analysis derived from 1005 
the mass spectrometric proteomics data for the 3 T-IEL subsets and WT and P14 LN T cells.  1006 
Supplementary File 2: PANTHER Gene Ontology enrichment analysis 1007 
Supplementary File 3: DAVID functional annotation enrichment analysis 1008 
Supplementary File 4 (related to Figure 4-8): Abbreviations and full protein names of proteins mentioned in 1009 
the text and figures.  1010 
Supplementary File 5 (related to Figure 7e-f): Proteins expressed in induced T-IEL and found to be 1011 
overrepresented in exhausted T cells gene set, and proteins missing or downregulated in induced T-IEL, 1012 
found to be underrepresented in exhausted T cells gene set (Khan et al, 2019). 1013 
Supplementary File 6: Set up of TMT labelling of samples for proteomics 1014 











